Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in YARW — Yarrow Bioscience, Inc.

CIK 1423053 MIAMI, FL
Back to YARW Full portfolio

Position in YARW

as of Jun 30, 2026 · filed Sep 2, 2026
Position Value
$304,965
-$2,671 QoQ
Shares Held
9,369
-8.9% QoQ
Ownership
0.351%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#8
of 44 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in YARW Over Time

Shares Held

Position Value (USD)

Derivatives in YARW

reported options exposure · as of Dec 31, 2022
CallValue
$0
CallShares
400
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,150,763,744 across 435 Biotechnology names. YARW ranks #295 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ONC
BeOne Medicines Ltd.
 1,425,517 $406,229,578
2 BBIO
BridgeBio Pharma, Inc.
 3,760,028 $280,046,885
3 INSM
INSMED Inc
 2,556,973 $272,624,460
4 MDGL
Madrigal Pharmaceuticals, Inc.
 507,233 $272,358,759
5 VRTX
Vertex Pharmaceuticals Inc / Ma
 510,430 $253,545,893
6 JAZZ
Jazz Pharmaceuticals plc
 1,006,676 $242,578,715
7 MANE
Veradermics, Inc
 1,877,775 $230,853,658
8 ROIV
Roivant Sciences Ltd.
 5,576,261 $197,343,876

All Filings in YARW

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $304,965 468,457
2026-03-31 $307,636 514,443
2025-12-31 $17,705 30,526
2025-06-30 $1,716,115 1,040,070
2025-03-31 $1,738,519 1,100,329
2024-12-31 $4,122,030 1,230,457
2024-09-30 $2,232,336 1,187,413
2024-06-30 $2,385,799 1,211,066
2024-03-31 $3,625,940 1,181,088
2023-12-31 $2,751,935 1,181,088